NIH-funded research R01 grant

Understanding how gut bacteria influence blood sugar and amino acids

Official title: Molecular mechanisms behind microbiota regulation of host amino acid and glucose homeostasis

Funded at Weill Medical Coll of Cornell Univ · NIH-11083753 · Data updated 2026-11-12

This study is looking at how the bacteria in our gut might help manage type 2 diabetes by affecting how our bodies process certain nutrients, and it's hoping to find ways to use these bacteria to improve diabetes care for people.

More Microbiota research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startApril 1, 2023
Project endMarch 31, 2028
Funding year2025
Award (this year)$491,469
NIH project number5R01DK135816-03
Project IDNIH-11083753 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk for or diagnosed with type 2 diabetes, particularly older adults.

Less likely to help

Patients who do not have type 2 diabetes or are not at risk for developing it may not benefit from this research.

What this research studies

This research investigates the relationship between gut microbiota and type 2 diabetes (T2D), particularly how gut bacteria affect amino acid metabolism and glucose regulation. By using advanced techniques in bioinformatics and metabolomics, the study aims to identify specific microbes that influence these metabolic pathways in mouse models of T2D. The ultimate goal is to develop engineered gut microbial communities that could help prevent or treat T2D in humans. This research could provide insights into the causal links between gut health and diabetes management.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing and treating type 2 diabetes through targeted manipulation of gut microbiota.

How similar studies have gone: Previous research has shown promising results in understanding the role of gut microbiota in metabolic diseases, suggesting that this approach could yield significant insights.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Guo, Chun-Jun — Weill Medical Coll of Cornell Univ
  • Study coordinator: Guo, Chun-Jun

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.